探索全水性不混合系统的潜力,以制备复杂的生物材料和细胞结构
Raquel C Gonçalves1, Mariana B Oliveira1, João F Mano1
1Department of Chemistry, CICECO - Aveiro Institute of Materials, University of Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal. mboliveira@ua.pt.
Materials horizons
|July 16, 2024
概括
全水性不混合系统为生物材料和组织工程提供了独特的特性. 本综述强调了使用这些先进的水性系统开发复杂生物材料和细胞结构的策略.
科学领域:
- 生物材料科学 生物材料科学
- 组织工程是组织工程.
- 生物技术是生物技术.
背景情况:
- 全水性不混合系统利用水友性剂的液-液相分离.
- 这些系统具有较低的界面张力,高透性和无毒的水相.
- 它们越来越多地被用于生物医学应用和组织工程.
研究的目的:
- 审查使用全水性不混合系统开发复杂生物材料的特性和最新策略.
- 探索它们在细胞封闭中的潜力,用于微模式和生物工程细胞丰富的结构.
- 为这个新兴领域的研究人员提供设计考虑.
主要方法:
- 对生物材料开发的最新策略的文献综述.
- 分析全水性不混合系统和接口的特性.
- 评估细胞模式和组织工程中的应用.
主要成果:
- 全水性不混合系统为水凝,膜和体外组织发育提供最佳质量.
- 最近的战略使得生物材料的复杂性增加.
- 这些系统对细胞限制的环境和生物工程应用有前途.
结论:
- 全水性不混合系统是用于先进生物材料设计的多功能平台.
- 提出了关键的设计考虑因素,以指导未来的研究.
- 未来的方向包括增强的仿生学和再生医学中的新应用.
相关概念视频
Bioreactor Design and Operational System
Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...
Bioreactor Controls-II
In aerobic fermentations, oxygen is vital for microbial growth and metabolite production. Since air comprises only about 20% oxygen and the gas is poorly soluble in water—just 9 ppm at 20°C—supplying sufficient oxygen becomes a critical challenge, especially in high-demand processes like yeast growth or citric acid production. Even a fully saturated broth may offer only a few seconds of oxygen availability.To address this, sterile or scrubbed air is introduced into the fermentor via a sparger...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Downstream Processing
Downstream processing begins once fermentation is complete and involves a series of steps to recover and purify products such as acids, vitamins, antibiotics, or proteins.Cell HarvestingFor example, for intracellular protein-based products, the first step is harvesting the cells. This is typically achieved using centrifugation or filtration to separate the cells from the liquid phase.Cell Disruption for Intracellular ProductsIf the target product is intracellular, the harvested cells must be...


